The BBB is one of the biggest obstacles in treating neurodegenerative diseases.
The solution found is to encapsulate therapeutic agents into biocompatible nanoparticles with precisely engineered surface properties that would enable their therapeutically effective transport into the brain, independent of the state of the BBB